{"id":749291,"date":"2023-04-19T16:36:28","date_gmt":"2023-04-19T20:36:28","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/profound-medical-to-release-first-quarter-2023-financial-results-on-may-10-conference-call-to-follow\/"},"modified":"2023-04-19T16:36:28","modified_gmt":"2023-04-19T20:36:28","slug":"profound-medical-to-release-first-quarter-2023-financial-results-on-may-10-conference-call-to-follow","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/profound-medical-to-release-first-quarter-2023-financial-results-on-may-10-conference-call-to-follow\/","title":{"rendered":"Profound Medical to Release First Quarter 2023 Financial Results on May 10 \u2013 Conference Call to Follow"},"content":{"rendered":"
\n

TORONTO, April 19, 2023 (GLOBE NEWSWIRE) — Profound Medical Corp.<\/a> (NASDAQ:PROF; TSX:PRN) (\u201cProfound\u201d or the \u201cCompany\u201d), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, will announce its first quarter 2023 financial results after market close on Wednesday, May 10, 2023.<\/p>\n

Profound management will host a conference call at 4:30 p.m. ET to review the financial results and discuss business developments in the period.<\/p>\n

\n First Quarter 2023 Results Conference Call Details:<\/strong>\n <\/p>\n\n\n\n\n
Date:<\/td>\nWednesday, May 10, 2023<\/td>\n<\/tr>\n
Time:<\/td>\n4:30 p.m. ET<\/td>\n<\/tr>\n
Live Call Registration:<\/td>\n\n https:\/\/register.vevent.com\/register\/BI314e0d7f1a8048c1a1f4117231db49be<\/a>\n <\/td>\n<\/tr>\n<\/table>\n

The call will also be broadcast live and archived on the Company’s website at www.profoundmedical.com<\/a> under “Webcasts” in the Investors section.<\/p>\n

\n About Profound Medical Corp.<\/strong>\n <\/p>\n

Profound is a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue.<\/p>\n

Profound is commercializing TULSA-PRO\u00ae<\/sup>, a technology that combines real-time MRI, robotically-driven transurethral ultrasound and closed-loop temperature feedback control. TULSA-PRO\u00ae<\/sup>\u00a0is designed to provide customizable and predictable radiation-free ablation of a surgeon-defined prostate volume while actively protecting the urethra and rectum to help preserve the patient\u2019s natural functional abilities. TULSA-PRO\u00ae<\/sup>\u00a0has the potential to be a flexible technology in customizable prostate ablation, including intermediate stage cancer, localized radio-recurrent cancer, retention and hematuria palliation in locally advanced prostate cancer, and the transition zone in large volume benign prostatic hyperplasia (\u201cBPH\u201d). TULSA-PRO\u00ae<\/sup> is CE marked, Health Canada approved, and 510(k) cleared by the U.S. Food and Drug Administration (\u201cFDA\u201d).<\/p>\n

Profound is also commercializing Sonalleve\u00ae<\/sup>, an innovative therapeutic platform that is CE marked for the treatment of uterine fibroids and palliative pain treatment of bone metastases. Sonalleve\u00ae<\/sup>\u00a0has also been approved by the China National Medical Products Administration for the non-invasive treatment of uterine fibroids and has FDA approval under a Humanitarian Device Exemption for the treatment of osteoid osteoma. The Company is in the early stages of exploring additional potential treatment markets for Sonalleve\u00ae<\/sup>\u00a0where the technology has been shown to have clinical application, such as non-invasive ablation of abdominal cancers and hyperthermia for cancer therapy.<\/p>\n

\n For further information, please contact:<\/strong>\n <\/p>\n

Stephen Kilmer
Investor Relations
skilmer@profoundmedical.com<\/a>
T: 647.872.4849\u00a0<\/p>\n


\n
\n \n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

TORONTO, April 19, 2023 (GLOBE NEWSWIRE) — Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (\u201cProfound\u201d or the \u201cCompany\u201d), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, will announce its first quarter 2023 financial results after market close on Wednesday, May 10, 2023. Profound management will host a conference call at 4:30 p.m. ET to review the financial results and discuss business developments in the period. First Quarter 2023 Results Conference Call Details: Date: Wednesday, May 10, 2023 Time: 4:30 p.m. ET Live Call Registration: https:\/\/register.vevent.com\/register\/BI314e0d7f1a8048c1a1f4117231db49be The call will also be broadcast live and archived on the Company’s website at www.profoundmedical.com under “Webcasts” in the Investors section. About Profound Medical Corp. Profound is … <\/p>\n

Continue reading “Profound Medical to Release First Quarter 2023 Financial Results on May 10 \u2013 Conference Call to Follow”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-749291","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nProfound Medical to Release First Quarter 2023 Financial Results on May 10 \u2013 Conference Call to Follow - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/profound-medical-to-release-first-quarter-2023-financial-results-on-may-10-conference-call-to-follow\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Profound Medical to Release First Quarter 2023 Financial Results on May 10 \u2013 Conference Call to Follow - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"TORONTO, April 19, 2023 (GLOBE NEWSWIRE) — Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (\u201cProfound\u201d or the \u201cCompany\u201d), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, will announce its first quarter 2023 financial results after market close on Wednesday, May 10, 2023. Profound management will host a conference call at 4:30 p.m. ET to review the financial results and discuss business developments in the period. First Quarter 2023 Results Conference Call Details: Date: Wednesday, May 10, 2023 Time: 4:30 p.m. ET Live Call Registration: https:\/\/register.vevent.com\/register\/BI314e0d7f1a8048c1a1f4117231db49be The call will also be broadcast live and archived on the Company’s website at www.profoundmedical.com under “Webcasts” in the Investors section. About Profound Medical Corp. Profound is … Continue reading "Profound Medical to Release First Quarter 2023 Financial Results on May 10 \u2013 Conference Call to Follow"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/profound-medical-to-release-first-quarter-2023-financial-results-on-may-10-conference-call-to-follow\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-04-19T20:36:28+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgxMTQyMCM1NTM2MTAzIzIwMTg1NDc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/profound-medical-to-release-first-quarter-2023-financial-results-on-may-10-conference-call-to-follow\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/profound-medical-to-release-first-quarter-2023-financial-results-on-may-10-conference-call-to-follow\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Profound Medical to Release First Quarter 2023 Financial Results on May 10 \u2013 Conference Call to Follow\",\"datePublished\":\"2023-04-19T20:36:28+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/profound-medical-to-release-first-quarter-2023-financial-results-on-may-10-conference-call-to-follow\\\/\"},\"wordCount\":379,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/profound-medical-to-release-first-quarter-2023-financial-results-on-may-10-conference-call-to-follow\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgxMTQyMCM1NTM2MTAzIzIwMTg1NDc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/profound-medical-to-release-first-quarter-2023-financial-results-on-may-10-conference-call-to-follow\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/profound-medical-to-release-first-quarter-2023-financial-results-on-may-10-conference-call-to-follow\\\/\",\"name\":\"Profound Medical to Release First Quarter 2023 Financial Results on May 10 \u2013 Conference Call to Follow - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/profound-medical-to-release-first-quarter-2023-financial-results-on-may-10-conference-call-to-follow\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/profound-medical-to-release-first-quarter-2023-financial-results-on-may-10-conference-call-to-follow\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgxMTQyMCM1NTM2MTAzIzIwMTg1NDc=\",\"datePublished\":\"2023-04-19T20:36:28+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/profound-medical-to-release-first-quarter-2023-financial-results-on-may-10-conference-call-to-follow\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/profound-medical-to-release-first-quarter-2023-financial-results-on-may-10-conference-call-to-follow\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/profound-medical-to-release-first-quarter-2023-financial-results-on-may-10-conference-call-to-follow\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgxMTQyMCM1NTM2MTAzIzIwMTg1NDc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgxMTQyMCM1NTM2MTAzIzIwMTg1NDc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/profound-medical-to-release-first-quarter-2023-financial-results-on-may-10-conference-call-to-follow\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Profound Medical to Release First Quarter 2023 Financial Results on May 10 \u2013 Conference Call to Follow\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Profound Medical to Release First Quarter 2023 Financial Results on May 10 \u2013 Conference Call to Follow - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/profound-medical-to-release-first-quarter-2023-financial-results-on-may-10-conference-call-to-follow\/","og_locale":"en_US","og_type":"article","og_title":"Profound Medical to Release First Quarter 2023 Financial Results on May 10 \u2013 Conference Call to Follow - Market Newsdesk","og_description":"TORONTO, April 19, 2023 (GLOBE NEWSWIRE) — Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (\u201cProfound\u201d or the \u201cCompany\u201d), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, will announce its first quarter 2023 financial results after market close on Wednesday, May 10, 2023. Profound management will host a conference call at 4:30 p.m. ET to review the financial results and discuss business developments in the period. First Quarter 2023 Results Conference Call Details: Date: Wednesday, May 10, 2023 Time: 4:30 p.m. ET Live Call Registration: https:\/\/register.vevent.com\/register\/BI314e0d7f1a8048c1a1f4117231db49be The call will also be broadcast live and archived on the Company’s website at www.profoundmedical.com under “Webcasts” in the Investors section. About Profound Medical Corp. Profound is … Continue reading \"Profound Medical to Release First Quarter 2023 Financial Results on May 10 \u2013 Conference Call to Follow\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/profound-medical-to-release-first-quarter-2023-financial-results-on-may-10-conference-call-to-follow\/","og_site_name":"Market Newsdesk","article_published_time":"2023-04-19T20:36:28+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgxMTQyMCM1NTM2MTAzIzIwMTg1NDc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/profound-medical-to-release-first-quarter-2023-financial-results-on-may-10-conference-call-to-follow\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/profound-medical-to-release-first-quarter-2023-financial-results-on-may-10-conference-call-to-follow\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Profound Medical to Release First Quarter 2023 Financial Results on May 10 \u2013 Conference Call to Follow","datePublished":"2023-04-19T20:36:28+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/profound-medical-to-release-first-quarter-2023-financial-results-on-may-10-conference-call-to-follow\/"},"wordCount":379,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/profound-medical-to-release-first-quarter-2023-financial-results-on-may-10-conference-call-to-follow\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgxMTQyMCM1NTM2MTAzIzIwMTg1NDc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/profound-medical-to-release-first-quarter-2023-financial-results-on-may-10-conference-call-to-follow\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/profound-medical-to-release-first-quarter-2023-financial-results-on-may-10-conference-call-to-follow\/","name":"Profound Medical to Release First Quarter 2023 Financial Results on May 10 \u2013 Conference Call to Follow - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/profound-medical-to-release-first-quarter-2023-financial-results-on-may-10-conference-call-to-follow\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/profound-medical-to-release-first-quarter-2023-financial-results-on-may-10-conference-call-to-follow\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgxMTQyMCM1NTM2MTAzIzIwMTg1NDc=","datePublished":"2023-04-19T20:36:28+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/profound-medical-to-release-first-quarter-2023-financial-results-on-may-10-conference-call-to-follow\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/profound-medical-to-release-first-quarter-2023-financial-results-on-may-10-conference-call-to-follow\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/profound-medical-to-release-first-quarter-2023-financial-results-on-may-10-conference-call-to-follow\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgxMTQyMCM1NTM2MTAzIzIwMTg1NDc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgxMTQyMCM1NTM2MTAzIzIwMTg1NDc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/profound-medical-to-release-first-quarter-2023-financial-results-on-may-10-conference-call-to-follow\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Profound Medical to Release First Quarter 2023 Financial Results on May 10 \u2013 Conference Call to Follow"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/749291","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=749291"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/749291\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=749291"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=749291"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=749291"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}